{"altmetric_id":1816948,"counts":{"readers":{"mendeley":25,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["NatRevClinOncol"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4e93cf058f61000243d","authors":["T Kinoshita","N Nohata","T Hanazawa","N Kikkawa","N Yamamoto","H Yoshino","T Itesako","H Enokida","M Nakagawa","Y Okamoto","N Seki"],"doi":"10.1038\/bjc.2013.607","endpage":"","first_seen_on":"2013-10-10T12:40:43+00:00","issns":["0007-0920","1532-1827"],"journal":"British Journal of Cancer","last_mentioned_on":1381408828,"links":["http:\/\/www.nature.com\/bjc\/journal\/vaop\/ncurrent\/full\/bjc2013607a.html"],"pubdate":"2013-10-03T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"","subjects":["neoplasms"],"title":"Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin|[ndash]|integrin signalling in head and neck squamous cell carcinoma","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/tumoursuppressive-microrna29s-inhibit-cancer-cell-migration-invasion-targeting-lamininintegrin-signa"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":3630565,"mean":4.929464153233,"rank":2899455,"this_scored_higher_than_pct":2,"this_scored_higher_than":79604,"rank_type":"exact","sample_size":3630565,"percentile":2},"similar_age_3m":{"total_number_of_other_articles":94645,"mean":7.7107535395802,"rank":74980,"this_scored_higher_than_pct":1,"this_scored_higher_than":371,"rank_type":"exact","sample_size":94645,"percentile":1},"this_journal":{"total_number_of_other_articles":2286,"mean":6.0385531728665,"rank":1917,"this_scored_higher_than_pct":2,"this_scored_higher_than":56,"rank_type":"exact","sample_size":2286,"percentile":2},"similar_age_this_journal_3m":{"total_number_of_other_articles":135,"mean":6.6047910447761,"rank":113,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":135,"percentile":1}}},"demographics":{"poster_types":{"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Unspecified":1,"Researcher":7,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":5,"Student  > Postgraduate":3,"Student  > Master":3,"Student  > Bachelor":2,"Professor":1},"by_discipline":{"Engineering":3,"Medicine and Dentistry":5,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":7,"Biochemistry, Genetics and Molecular Biology":6,"Unspecified":3}}},"geo":{"twitter":{"GB":1},"mendeley":{"US":1,"GB":1,"PT":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/NatRevClinOncol\/status\/388282886291353600","license":"public","citation_ids":[1816948],"posted_on":"2013-10-10T12:40:28+00:00","author":{"name":"NatureRevClinOncol","url":"http:\/\/www.nature.com\/nrclinonc\/index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/1587954262\/nrclinonc_Twitter_logo_normal.jpg","description":"The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.","id_on_source":"NatRevClinOncol","tweeter_id":"347276297","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":10325},"tweet_id":"388282886291353600"}]}}